SEC Form 4 · accession 0001382963-15-000126
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock, par value $0.01F1 | Oct 28, 2015 | A | 2,529 | $0.00 | A | 35,079 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares will vest in full at the 2016 Annual Shareholders Meeting.